Regression of Established Tumors in Mice Mediated by the Oral Administration of a Recombinant Listeria monocytogenes Vaccine

Cancer Research

Volumn 55, Issue 21, 1995, Pages 4776-4779

  Pan, Zhen Kun ^a   Ikonomidis, Georgios ^a   Paterson, Yvonne ^a   Pardoll, Daew ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLORECTAL TUMOR; IMMUNE SYSTEM; IMMUNOTHERAPY; KIDNEY TUMOR; LISTERIA MONOCYTOGENES; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR REGRESSION;

ADMINISTRATION, ORAL; ANIMAL; ANTIGENS, NEOPLASM; ANTIGENS, VIRAL; BACTERIAL VACCINES; CARCINOMA, RENAL CELL; COLONIC NEOPLASMS; GENE PRODUCTS, GAG; IMMUNOTHERAPY, ACTIVE; KIDNEY NEOPLASMS; LISTERIA MONOCYTOGENES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; NUCLEOPROTEINS; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES, CYTOTOXIC; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; VACCINES, SYNTHETIC; VIRAL CORE PROTEINS;

EID: 0028799266     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Pan, Z.-K., Ikonomidis, G.M., Lazenby, A., Pardoll, D., and Paterson, Y. A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour challenge and causes regression of established tumours. Nat. Med., 7:471–477, 1995.
2. Kaufmann, S. H. E. Immunity to intracellular bacteria. Annu. Rev. Immunol., II: 129–163, 1993.
3. Ikonomidis, G., Paterson, Y., Kos, F. J., and Portnoy, D. A. Delivery of a viral antigen to the class I processing and presentation pathway of Listeria monocytogenes. J. Exp. Med., 180:2209–2218, 1994.
4. Fearon, E. R., Itaya, T., Hunt, B., Vogelstein, B., and Frost, P. Induction in a murine tumour of immunogenic tumour variants by transfection with a foreign gene. Cancer Res., 38:2975–2980, 1988.
5. Murphy, G. P., and Hushresky, W. J. J. A murine renal cell carcinoma. J. Natl. Cancer Inst., 50:1013–1025, 1973.
6. Fidler, I. J. Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res., 35:218–234, 1975.
7. Fetten, J. H., Roy, N., and Gilboa, E. A frameshift mutation at the NH2 terminus of the nucleoprotein gene does not affect generation of cytotoxic T lymphocyte epitopes. J. Immunol., 147:2697–2705, 1991.
8. Huang, A. Y., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., and Levitsky, H. Role of bone-marrow derived cells in presenting MHC class I restricted tumour antigens. Science (Washington DC), 264:961–965, 1994.
9. Camilli, A., Tilney, L. G., and Portnoy, D. A. Dual roles of pick in Listeria monocytogenes pathogenesis. Mol. Microbiol. 8:143–157, 1993.
10. Bodmer, H. C., Pemberton, R. M., Rothbard, J. B., and Askonas, B. A. Enhanced recognition of a modified peptide antigen by cytotoxic T cells specific for influenza nucleoprotein. Cell, 52:253–258, 1988.
11. Racz, P., Tenner, K. and Mero, E. Experimental Listeria enteritis. I. An electron microscope study of the epithelial phase in experimental listen a I infection. Lab. Invest., 26:694–700, 1972.
12. Slingluff, C. L., Hunt, D. F., and Engelhard, V. H. Direct analysis of tumour-associated peptide antigens. Curr. Opin. Immunol., 6:733–740, 1994.
13. Boon, T., Cerottini, J.-C., Van den Eynde, B., and van der Bruggen, P. Tumour antigens recognized by T lymphocytes. Annu. Rev. Immunol., 12:337–365, 1994.
14. Pardoll, D. M. Paracrine cytokine adjuvants in cancer immunotherapy. Annu. Rev. Immunol., 13:399–415, 1995.
15. Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D., and Mulligan, R.C. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA, 20:3539–3543, 1993.
16. Baskar, S., Ostrand-Rosenberg, S., Nabavi, N., Nadler, L. M., Freeman, G. J., and Glimcher, L. H. Constitutive expression of B7 restores the immunogenicity of tumour cells expressing truncated MHC class II molecules. Proc. Natl. Acad. Sci. USA, 90:5687–5690, 1993.
17. Wu, T.-C. Immunology of the human papilloma virus in relation to cancer. Curr. Opin. Immunol., 6:728–732, 1994.
18. Ikonomidis, G., Frankel, F. R., Portnoy, D. A., and Paterson, Y. Listeria monocytogenes:a novel live vaccine vector. In:F. Brown, R. Charnock, H. Ginsberg, and E. Norrby (eds.), Vaccines 95:Molecular Approaches to the Control of Infectious Diseases, pp. 317–326. Cold Spring Harbor, NY:Cold Spring Harbor Laboratory.